These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

100 related articles for article (PubMed ID: 29016353)

  • 21. Exploring the idiotypes of insulin antibodies as markers for remission in Type 1 diabetes.
    Devendra D; Galloway TS; Horton SJ; Wilkin TJ
    Diabet Med; 2004 Dec; 21(12):1316-24. PubMed ID: 15569135
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Effects of methylprednisolone pulse therapy on insulin injections in patients with insulin-dependent diabetes mellitus.
    Satman I; Fiçicioğlu C; Karşidağ K; Yilmaz T; Dinçdağ N; Koca F; Odabaşi F; Aydin A; Devrim S; Haktan M
    Turk J Pediatr; 1996; 38(4):419-29. PubMed ID: 8993171
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Changes in high-density lipoprotein cholesterol (HDL-C) level and the ratio of triglycerides to HDL-C during the first year of type 1 diabetes.
    Cieluch A; Uruska A; Grzelka-Woźniak A; Niedźwiecki P; Flotyńska J; Zozulińska-Ziółkiewicz D
    Pol Arch Intern Med; 2019 Sep; 129(9):598-604. PubMed ID: 31379357
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Candidate Biomarkers for the Prediction and Monitoring of Partial Remission in Pediatric Type 1 Diabetes.
    Gomez-Muñoz L; Perna-Barrull D; Caroz-Armayones JM; Murillo M; Rodriguez-Fernandez S; Valls A; Vazquez F; Perez J; Corripio R; Castaño L; Bel J; Vives-Pi M
    Front Immunol; 2022; 13():825426. PubMed ID: 35280980
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Menarche in type 1 diabetes is still delayed despite good metabolic control.
    Picardi A; Cipponeri E; Bizzarri C; Fallucca S; Guglielmi C; Pozzilli P
    Fertil Steril; 2008 Nov; 90(5):1875-7. PubMed ID: 18191849
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Glucose evaluation trial for remission (GETREM) in type 1 diabetes: a European multicentre study.
    Pozzilli P; Manfrini S; Buzzetti R; Lampeter E; Leeuw ID; Iafusco D; Prisco M; Ionescu-Tirgoviste C; Kolouskovà S; Linn T; Ludvigsson J; Madàcsy L; Mrozikiewicz AS; Mrozikiewicz PM; Podar T; Vavrinec J; Vialettes B; Visalli N; Yilmaz T; Browne PD;
    Diabetes Res Clin Pract; 2005 Jun; 68(3):258-64. PubMed ID: 15936469
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Pubertal Lipid Levels Are Significantly Lower in Youth With Type 1 Diabetes Who Experienced Partial Clinical Remission.
    Nwosu BU; Rupendu S; Zitek-Morrison E; Patel D; Villalobos-Ortiz TR; Jasmin G; Barton BA
    J Endocr Soc; 2019 Apr; 3(4):737-747. PubMed ID: 30931423
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Association of immune mediators at diagnosis of Type 1 diabetes with later clinical remission.
    Schloot NC; Hanifi-Moghaddam P; Aabenhus-Andersen N; Alizadeh BZ; Saha MT; Knip M; Devendra D; Wilkin T; Bonifacio E; Roep BO; Kolb H; Mandrup-Poulsen T
    Diabet Med; 2007 May; 24(5):512-20. PubMed ID: 17381505
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Autologous hematopoietic stem cell transplantation and conventional insulin therapy in the treatment of children with newly diagnosed type 1 diabetes: long term follow-up.
    Gu Y; Gong C; Peng X; Wei L; Su C; Qin M; Wang X; Li F
    Chin Med J (Engl); 2014; 127(14):2618-22. PubMed ID: 25043077
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Partial Clinical Remission of Type 1 Diabetes: The Need for an Integrated Functional Definition Based on Insulin-Dose Adjusted A1c and Insulin Sensitivity Score.
    Nwosu BU
    Front Endocrinol (Lausanne); 2022; 13():884219. PubMed ID: 35592786
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Osteocalcin, adipokines and their associations with glucose metabolism in type 1 diabetes.
    Neumann T; Lodes S; Kästner B; Franke S; Kiehntopf M; Lehmann T; Müller UA; Wolf G; Sämann A
    Bone; 2016 Jan; 82():50-5. PubMed ID: 25888930
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Association between sitagliptin plus vitamin D3 (VIDPP-4i) use and clinical remission in patients with new-onset type 1 diabetes: a retrospective case-control study.
    Pinheiro MM; Pinheiro FMM; de Arruda MM; Beato GM; Verde GACL; Bianchini G; Casalenuovo PRM; Argolo AAA; de Souza LT; Pessoa FG; Hirose TS; Senra EF; Ricordi C; Fabbri A; Infante M; Diniz SN
    Arch Endocrinol Metab; 2023 May; 67(5):e000652. PubMed ID: 37249465
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Redefining the clinical remission period in children with type 1 diabetes.
    Chase HP; MacKenzie TA; Burdick J; Fiallo-Scharer R; Walravens P; Klingensmith G; Rewers M
    Pediatr Diabetes; 2004 Mar; 5(1):16-9. PubMed ID: 15043685
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Benefits of continuous subcutaneous insulin infusion in children with type 1 diabetes mellitus].
    Hasselmann C; Bonnemaison E; Faure N; Mercat I; Bouillo Pépin-Donat M; Magontier N; Chantepie A; Labarthe F
    Arch Pediatr; 2012 Jun; 19(6):593-8. PubMed ID: 22584198
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Partial remission phase of diabetes in children younger than age 10 years.
    Muhammad BJ; Swift PG; Raymond NT; Botha JL
    Arch Dis Child; 1999 Apr; 80(4):367-9. PubMed ID: 10086946
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Secular trends of body mass index in North Indian children with Type 1 diabetes do not support the Accelerator Hypothesis.
    Dayal D; Samprathi M; Jayaraman D; Kohat D; Bhalla AK
    Clin Endocrinol (Oxf); 2016 Mar; 84(3):338-41. PubMed ID: 26342175
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Smoking and other factors associated with short-term partial remission of Type 1 diabetes in adults.
    Pilacinski S; Adler AI; Zozulinska-Ziolkiewicz DA; Gawrecki A; Wierusz-Wysocka B
    Diabet Med; 2012 Apr; 29(4):464-9. PubMed ID: 21978224
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Association of interferon-gamma and interleukin 10 genotypes and serum levels with partial clinical remission in type 1 diabetes.
    Alizadeh BZ; Hanifi-Moghaddam P; Eerligh P; van der Slik AR; Kolb H; Kharagjitsingh AV; Pereira Arias AM; Ronkainen M; Knip M; Bonfanti R; Bonifacio E; Devendra D; Wilkin T; Giphart MJ; Koeleman BP; Nolsøe R; Mandrup Poulsen T; Schloot NC; Roep BO;
    Clin Exp Immunol; 2006 Sep; 145(3):480-4. PubMed ID: 16907917
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Insulin resistance in children and adolescents with type 1 diabetes mellitus: relation to obesity.
    Reinehr T; Holl RW; Roth CL; Wiesel T; Stachow R; Wabitsch M; Andler W;
    Pediatr Diabetes; 2005 Mar; 6(1):5-12. PubMed ID: 15787895
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Medication use in diabetes mellitus (VI). Economics and effectiveness of insulin and sulfonyl-urea combination therapy compared with conventional two daily doses].
    Costa B; Estopá A; Borrás J; Sabaté A
    Med Clin (Barc); 1998 Nov; 111(15):568-72. PubMed ID: 9859089
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.